BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15770927)

  • 1. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
    Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
    Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
    Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
    Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; Faict D; Gericke M; Lameire N; De Vriese A
    Nephron Exp Nephrol; 2005; 101(4):e139-45. PubMed ID: 16131808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.
    Mortier S; De Vriese AS; McLoughlin RM; Topley N; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2003 May; 14(5):1296-306. PubMed ID: 12707398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis.
    Zareie M; van Lambalgen AA; De Vriese AS; van Gelderop E; Lameire N; ter Wee PM; Beelen RH; van den Born J; Tangelder GJ
    Perit Dial Int; 2002; 22(6):655-62. PubMed ID: 12556066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
    Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
    Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.
    Mortier S; De Vriese AS; Van de Voorde J; Schaub TP; Passlick-Deetjen J; Lameire NH
    J Am Soc Nephrol; 2002 Feb; 13(2):480-489. PubMed ID: 11805178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.
    Zareie M; Hekking LH; Welten AG; Driesprong BA; Schadee-Eestermans IL; Faict D; Leyssens A; Schalkwijk CG; Beelen RH; ter Wee PM; van den Born J
    Nephrol Dial Transplant; 2003 Dec; 18(12):2629-37. PubMed ID: 14605288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of a chronic rat model for peritoneal dialysis by using heparin-coated catheters.
    Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
    Adv Perit Dial; 2004; 20():150-4. PubMed ID: 15384817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role for mast cells in omental tissue remodeling and cell recruitment in experimental peritoneal dialysis.
    Zareie M; Fabbrini P; Hekking LH; Keuning ED; Ter Wee PM; Beelen RH; van den Born J
    J Am Soc Nephrol; 2006 Dec; 17(12):3447-57. PubMed ID: 17065241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term intervention with heparins in a rat model of peritoneal dialysis.
    Schilte MN; Loureiro J; Keuning ED; ter Wee PM; Celie JW; Beelen RH; van den Born J
    Perit Dial Int; 2009; 29(1):26-35. PubMed ID: 19164250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.
    Hekking LHP; Zareie M; Driesprong BAJ; Faict D; Welten AGA; de Greeuw I; Schadee-Eestermans IL; Havenith CEG; van den Born J; Ter Wee PM; Beelen RHJ
    J Am Soc Nephrol; 2001 Dec; 12(12):2775-2786. PubMed ID: 11729248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of icodextrin on integrin-mediated wound healing of peritoneal mesothelial cells.
    Matsumoto M; Tamura M; Miyamoto T; Furuno Y; Kabashima N; Serino R; Shibata T; Kanegae K; Takeuchi M; Abe H; Okazaki M; Otsuji Y
    Life Sci; 2012 Jun; 90(23-24):917-23. PubMed ID: 22564410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats.
    Wieczorowska-Tobis K; Polubinska A; Schaub TP; Schilling H; Wisniewska J; Witowski J; Passlick-Deetjen J; Breborowicz A
    Perit Dial Int; 2001; 21 Suppl 3():S108-13. PubMed ID: 11887803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis.
    Fabbrini P; Schilte MN; Zareie M; ter Wee PM; Keuning ED; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2009 Dec; 24(12):3669-76. PubMed ID: 19666665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.